Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure

Journal of Hypertension

Volumn 27, Issue 12, 2009, Pages 2483-2491

  Plaksej, Rafal ^a   Kosmala, Wojciech ^a   Frantz, Stefan ^b   Herrmann, Sebastian ^b   Niemann, Markus ^b   Störk, Stefan ^b   Wachter, Rolf ^e   Angermann, Christiane E ^b   Ertl, Georg ^b   Bijnens, Bart ^c,d   Weidemann, Frank ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Echocardiography; Fibrosis markers; Heart failure; Hypertension; Left ventricular function; Right ventricular function; Strain

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; ESSENTIAL HYPERTENSION; FEMALE; HEART DISEASE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DYSFUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSFUNCTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 73649122839     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283316c4d     Document Type: Article

References (37)

1. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275:15571562. (Pubitemid 26154241)
2. Richards AM, Nicholls MG, Troughton RW. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39:11821188.
3. Bountioukos M, Schinkel AFL, Bax JJ, Lampropoulos S, Poldermans D. The Impact of hypertension on systolic and diastolic left ventricular function. A tissue Doppler echocardiographic study. Am Heart J 2006; 151:1323e7-1323e12. (Pubitemid 43866620)
4. Yuda S, Short L, Leano R, Marwlck TH. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Science 2002; 103:183-193.
5. Cicala S, Galderisi M, Caso P, Petrocelli A, D'Errico A, de Divitiis O, Calabro R. Right ventricular diastolic dysfunction in arterial systemic hypertension: analysis by pulsed tissueEur doppler. Eur J Echocardiogr 2002; 3:135-142.
6. Habib GB, Zoghbi WA. Doppler assessment of right ventricular filling dynamics in systemic hypertension: comparison with left ventricular filling. Am Heart J 1992; 124:1313-1320.
7. Mahmud M, Champion HC. Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies. Curr Cardiol Rep 2007; 9:200-208.
8. Giannakoulas G, Parcharidou D, Efthimiadis G, Karvounis H, Styliadis I, Parcharidis G. Right ventricular dysfunction in chronic heart failure. Am J Cardiol 2008; 101:1070.
9. Mundhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Arch 1997; 431:265-273.
10. Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, Diez J. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98:535-540. (Pubitemid 28371251)
11. Berk BC, Fujiwara K, Lehoux S. ECM remodeling In hypertensive heart disease. J Clin Invest 2007; 117:568-575. (Pubitemid 46348511)
12. Demir M, Acartuerk E, Inal T, Attila G, Doenmez Y, Avkarogullari M, Cayli M. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients. Cardiovasc Pathol 2007; 16: 69-74. (Pubitemid 46274405)
13. Sugihara N, Genda A, Shimizu M, Suematsu T, Kita Y, Minamoto M, et al. Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension. J Cardiol 1988; 18:353-361. (Pubitemid 19042584)
14. Ohsato K, Shimizu M, Sugihara N, Konishi K, Takeda R. Histopathological factors related to diastolic function in myocardial hypertrophy. Jpn Circ J 1992;56:325-333.
15. Poulsen SH, Andersen NH, Heickendorff L, Mogensen CE. Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension. Heart 2005; 91:624-629. (Pubitemid 40559353)
16. Zannad F, Alla F, Dousset B, Perez A, Pitt B, on behalf of the RALES Investigators. Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES). Circulation 2000; 102:2700-2706. (Pubitemid 30949246)
17. Diez J, Querejeta R, Lopez B, González A, Larman M, Martinez Ubago JL Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105:2512-2517. (Pubitemid 34568973)
18. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000; 102:1388-1393.
19. López B, Querejeta R, Varo N, González A, Larman M, Martinez Ubago JL, Diez J. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardloreparative ability of antihypertensive treatment In hypertensive patients. Circulation 2001 ; 104:286-291. (Pubitemid 32666949)
20. Kosmala W, Plaksej R, Strotmann JM, Weigel C, Herrmann S, Niemann M, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr 2008; 21:1309-1317.
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
22. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458. (Pubitemid 16119719)
23. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on Diagnosis and Treatment of Pulmonary Arterial Hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 26:2243-2278. (Pubitemid 39610407)
24. Cockcroft D, Gault MD. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
25. Gottdiener JS, Gay JA, Maron BJ, Fletcher RD. Increased right ventricular wall thickness In left ventricular pressure overload: echocardiographic determination of hypertrophic response of the non stressed ventricle. J Am Coll Cardiol 1986; 6:550-555.
26. Baker KM, Chernin Ml, Wixson SK, Aceto JF. Renin-angiotensin system imvolment In pressure overload cardiac hypertrophy in rats. Am J Physiol 1980;259:H324-H332.
27. Komuro M, Kurabyashi M, Takuku F, Yazaki Y. Expression cellular oncogenes in the myocardium during the developmental stage and pressure overload hypertrophy of the rat heart. Circ Res 1988; 62:1075-1079. (Pubitemid 18169593)
28. Querejeta R, Varo N, López B, Larman M, Artiñano E, Etayo JC, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000; 101:1729-1735. (Pubitemid 30196635)
29. Querejeta R, López B, González A, Sánchez E, Larman M, Martinez Ubago JL, Diez J. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 2004; 110:1263-1268. (Pubitemid 39202343)
30. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation 1995; 91:1450-1456.
31. Lopez B, Gonzalez A, Querejeta R, Larman M, Diez J. Alterations In the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failire. J Am Coll Cardiol 2006; 48:89-96. (Pubitemid 43929208)
32. Iwanaga Y, Aoyama T, Kihara Y, Onozawa Y, Yoneda T, Sasayama S. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 2002; 39:1384-1391. (Pubitemid 34297882)
33. Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail 2002; B (suppl 6):S319-S325. (Pubitemid 36083078)
34. Diez J, Panizo A, Gil MJ, Monreal I, Hernández M, Pardo Mindán J. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis. Circulation 1996; 93:1026-1032. (Pubitemid 26074839)
35. Lindsay MM, Maxwell P, Dunn FG. TIMP-1 : a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40:136-141. (Pubitemid 34840088)
36. Maciver DH, Townsend M. A novel mechanism of heart failure with normal ejection fraction. Heart 2008; 94:446-449.
37. Brilla CG. Regression of myocardial fibrosis In hypertensive heart disease: diverse effects of various antihypertensive drugs. Cardiovasc Res 2000; 46:324-331.